• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Masimo Corp

NASDAQ:MASI

$19.32 -$0.10 (-0.51%)

REAL-TIME: Last trade at

Masimo announces published study of rainbow Acoustic Monitoring efficacy

First Published Study on Masimo Acoustic Respiration Rate Demonstrates Significantly Higher Patient Tolerance and Similar Accuracy Compared to Capnometry in Post-Surgical Patients

Masimo signs three-year agreement with Novation

Masimo reports Q1 EPS 27c, consensus 27c

Masimo Corporation (MASI) Reports In-Line Q1 EPS

Masimo management to meet with BMO Capital

Masimo to Present at Deutsche Bank Securities 37th Annual Health Care Conference

Masimo announces new low-profile infant, neonatal pulse oximetry sensors

Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors

Masimo initiated with a Market Perform at Raymond James

Essential Medical dismisses patent case against Masimo and Cercacor

Essential Medical Dismisses Patent Case against Masimo and Cercacor

Masimo says study shows PVI results similar to more costly, invasive method

New Study Shows Masimo's Noninvasive Pleth Variability Index Provides Similar Ability to Assess Fluid Responsiveness During Surgery as More Costly and Invasive Method

Masimo to Report First Quarter 2012 Financial Results after Market Close on May 2

Masimo Pronto-7 receives China, South Korea regulatory clearances

Masimo Pronto-7™ Receives China and South Korea Regulatory Clearances

Masimo, Fortis Healthcare sign multi-year technology supplier agreement

Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions

Masimo Debuts 2012 Radical-7® at World Congress of Anaesthesiologists

Masimo Acquires Assets of Spire Semiconductor to Advance Innovation, Speed Development, and Reduce Costs

Masimo acquires assets of Spire Semiconductor

Masimo to Present at 24th Annual ROTH Conference

2012 Economic Outlook - Report Highlights Halozyme Therapeutics, Inc. and Masimo Corporation

Masimo and GE Helathcare announce agreement

GE Healthcare Partners With Masimo to Incorporate rainbow® SET Technology With GE Patient Monitors

8 Stocks Rising on Huge Volume

Brean Murray Carret Raises Price Target on Masimo (MASI) Following Q4 Results

Masimo 2012 guidance may prove conservative, says Collins Stewart

Masimo price target raised to $26 from $24 at Brean Murray

Masimo Corp. (MASI) Reports In-Line Q4 EPS; Issues Stronger FY12 Outlook

Masimo sees FY12 EPS $1.20 vs. consensus $1.19

Masimo Announces "Better Care" Program - A Hospital Risk-Share Program for Blood Transfusion Related Cost Reduction with SpHb®, and $30 SpHb Sensor Price

Cramer's Homework, C&J Energy, Guidewire and More

Citi Downgrades Masimo Corp. (MASI) to Sell, Reduces Price Target to $20

Masimo downgraded to Sell from Neutral at Citigroup

Masimo to Report Fourth Quarter and Full Year 2011 Financial Results After Market Close on February 14, 2012

Respiratory Measurement Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Piper Jaffray's medtech research team holds a conference call

Brean Murray Carret & Co. Maintains a 'Buy' on Masimo (MASI); More Optimistic Near-Term

See More Articles...